Innoviva, Inc.

Nasdaq:INVA

Pharmaceutical Preparations·BURLINGAME, CA

CFO

Basso Stephen

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/25/26	→
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/6/25	→
10-Q	Q1 2025	3/31/25	5/7/25	→
10-K/A	FY 2024	12/31/24	3/24/25	→
10-K	FY 2024	12/31/24	2/26/25	→
↓

Earnings Releases (8-K)

32 shown

Filed	Period
2/25/26	Q1 FY2026	→
11/5/25	Q4 FY2025	→
8/6/25	Q3 FY2025	→
5/7/25	Q2 FY2025	→
2/26/25	Q1 FY2025	→
11/6/24	Q4 FY2024	→
↓

News (8-K)

48 shown

Filed	Type	Description
5/21/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/20/24	Vote	Submission of Matters to a Vote of Security Holders	→
5/13/24	Reg FD	Regulation FD Disclosure	→
4/30/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/6/23	Reg FD	Regulation FD Disclosure	→
8/25/23	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

11 shown

Filed	Form	Description
4/8/25	ARS	ARS	→
5/9/24	ARS	ARS	→
11/13/23	S-8	S-8	→
4/28/23	ARS	ARS	→
8/7/14	S-8	S-8	→
1/18/13	424B5	424B5	→
↓

Filing History(1003 filings)

TypeDateAccessionPeriodSize

8-K

Feb 25, 2026

0001193125-26-0719748-K

Feb 25, 2026

256.4 KB

10-K

Feb 25, 2026

0001193125-26-07177610-K

Dec 31, 2025

31.1 MB

Feb 24, 2026

0001193125-26-0670294

Feb 20, 2026

4.8 KB

Feb 24, 2026

0001193125-26-0670244

Feb 20, 2026

4.7 KB

Feb 24, 2026

0001193125-26-0670224

Feb 20, 2026

4.7 KB

SCHEDULE 13G/A

Feb 12, 2026

0001037389-26-000014

—

9.4 KB

SCHEDULE 13D/A

Jan 26, 2026

0001140361-26-002376

—

18.4 KB

SCHEDULE 13G/A

Jan 21, 2026

0000354204-26-000281

—

8.7 KB

Nov 24, 2025

0001104659-25-115427OWNERSHIP DOCUMENT

Nov 20, 2025

6.6 KB

Nov 24, 2025

0001104659-25-115425OWNERSHIP DOCUMENT

Nov 20, 2025

4.9 KB

Nov 5, 2025

0001104659-25-107236OWNERSHIP DOCUMENT

Nov 3, 2025

5.7 KB

Nov 5, 2025

0001104659-25-107234OWNERSHIP DOCUMENT

Nov 3, 2025

7.3 KB

10-Q

Nov 5, 2025

0001193125-25-26704010-Q

Sep 30, 2025

15.3 MB

8-K

Nov 5, 2025

0001104659-25-107014FORM 8-K

Nov 5, 2025

338.3 KB

SCHEDULE 13G/A

Oct 8, 2025

0001085146-25-005840

—

7.0 KB

SCHEDULE 13G/A

Sep 3, 2025

0001085146-25-005711

—

7.4 KB

Aug 22, 2025

0001104659-25-081891OWNERSHIP DOCUMENT

Aug 20, 2025

4.9 KB

Aug 22, 2025

0001104659-25-081888OWNERSHIP DOCUMENT

Aug 20, 2025

4.9 KB

SCHEDULE 13G/A

Aug 13, 2025

0001037389-25-000050

—

9.4 KB

SCHEDULE 13D/A

Aug 12, 2025

0001140361-25-030666

—

13.0 KB

10-Q

Aug 6, 2025

0000950170-25-10412610-Q

Jun 30, 2025

14.9 MB

8-K

Aug 6, 2025

0001104659-25-074730FORM 8-K

Aug 6, 2025

318.1 KB

SCHEDULE 13G

Aug 6, 2025

0001085146-25-004605

—

7.3 KB

SCHEDULE 13G/A

Aug 5, 2025

0000038777-25-000147

—

24.2 KB

May 22, 2025

0001104659-25-052002OWNERSHIP DOCUMENT

May 20, 2025

4.9 KB

25 filings shown

Filed	Form	Description
4/8/25	DEFA14A	DEFA14A	→
4/8/25	DEF 14A	DEF 14A	→
4/29/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
5/17/23	DEFA14A	DEFA14A	→
5/1/23	DEFA14A	DEFA14A	→
↓

Innoviva, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1003 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/24/26	4	4	→
2/24/26	4	4	→
2/24/26	4	4	→
11/24/25	4	OWNERSHIP DOCUMENT	→
11/24/25	4	OWNERSHIP DOCUMENT	→
11/5/25	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
2/12/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/26/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
1/21/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/8/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
9/3/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓